1. Home
  2. XBIO vs SGLY Comparison

XBIO vs SGLY Comparison

Compare XBIO & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XBIO
  • SGLY
  • Stock Information
  • Founded
  • XBIO N/A
  • SGLY 2001
  • Country
  • XBIO United States
  • SGLY United States
  • Employees
  • XBIO N/A
  • SGLY N/A
  • Industry
  • XBIO Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • XBIO Health Care
  • SGLY
  • Exchange
  • XBIO Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • XBIO 4.2M
  • SGLY 3.7M
  • IPO Year
  • XBIO N/A
  • SGLY 2008
  • Fundamental
  • Price
  • XBIO $2.96
  • SGLY $0.92
  • Analyst Decision
  • XBIO Hold
  • SGLY
  • Analyst Count
  • XBIO 1
  • SGLY 0
  • Target Price
  • XBIO N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • XBIO 6.9K
  • SGLY 457.6K
  • Earning Date
  • XBIO 05-13-2025
  • SGLY 05-15-2025
  • Dividend Yield
  • XBIO N/A
  • SGLY N/A
  • EPS Growth
  • XBIO N/A
  • SGLY N/A
  • EPS
  • XBIO N/A
  • SGLY N/A
  • Revenue
  • XBIO $2,582,728.00
  • SGLY $2,172,036.00
  • Revenue This Year
  • XBIO $14.23
  • SGLY N/A
  • Revenue Next Year
  • XBIO $7.14
  • SGLY N/A
  • P/E Ratio
  • XBIO N/A
  • SGLY N/A
  • Revenue Growth
  • XBIO 5.63
  • SGLY N/A
  • 52 Week Low
  • XBIO $2.20
  • SGLY $0.54
  • 52 Week High
  • XBIO $5.20
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • XBIO 48.28
  • SGLY 50.30
  • Support Level
  • XBIO $2.85
  • SGLY $0.82
  • Resistance Level
  • XBIO $3.22
  • SGLY $1.03
  • Average True Range (ATR)
  • XBIO 0.14
  • SGLY 0.14
  • MACD
  • XBIO -0.00
  • SGLY -0.01
  • Stochastic Oscillator
  • XBIO 26.91
  • SGLY 15.08

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: